Determination of Pancreatic Steatosis Prevalence and Correlation With High-risk Cyst Features
- Conditions
- Pancreatic SteatosisPancreatic Cyst
- Registration Number
- NCT05334836
- Lead Sponsor
- Chinese University of Hong Kong
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 236
Inclusion Criteria:<br><br> 1. Age 18 or older<br><br> 2. Patients with at least 1 pancreatic cystic lesion presumed to be IPMN or MCN based<br> on CT, MRI or EUS features, with a cyst size = 5mm; or healthy subjects.<br><br> 3. Patients who are able to provide written informed consent to participate in the<br> study and comply with the study procedures.<br><br>Exclusion Criteria:<br><br> 1. Unable to provide written informed consent<br><br> 2. Patients with metallic implants or other contraindications to MRI<br><br> 3. Patients with contraindications for endoscopy due to comorbidities<br><br> 4. Patients with known pancreatic cancer or prior pancreatic resection<br><br> 5. Patients with significant alcohol consumption, defined as alcohol intake of over 20<br> g daily (140 g weekly) for men and 10 g daily (70 g weekly) for women
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevalence of pancreatic steatosis determined by fat quantitation on MRI
- Secondary Outcome Measures
Name Time Method Prevalence of worrisome features or high-risk stigmata on baseline EUS in patients with presumed IPMN or MCN and pancreatic steatosis;Prevalence of worrisome features or high-risk stigmata on baseline EUS in patients with presumed IPMN or MCN without pancreatic steatosis;Prevalence of coexisting fatty liver and fatty pancreas, fatty liver alone, or fatty pancreas alone in patients with presumed IPMN or MCN;Risk factors for pancreatic steatosis in patients with presumed IPMN or MCN
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.